跳至主要内容
临床试验/NCT06636188
NCT06636188招募中不适用

An Oncology Nurse Artificial Intelligence Agent to Reduce Cancer Distress of Patients Undergoing Radiotherapy: A Mixed-Methods Randomized Controlled Trial

The University of Hong Kong2 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2026年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
138
试验地点
2
主要终点
National Comprehensive Cancer Network Distress Thermometer

研究概览

简要总结

The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer.

The main question it aims to answer is: How effective is the Digi-Coach chatbot in reducing physical and psychological distress?

Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer.

Participants will have access to the Digi-Coach chatbot during radiotherapy in addition to usual care. The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot.

详细描述

The goal of this clinical trial is to assess the effectiveness of the Digi-Coach chatbot for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer.

The main question it aims to answer is: How effective is the Digi-Coach chatbot in reducing physical and psychological distress? Researchers will compare Digi-Coach chatbot to usual nursing care to see if Digi-Coach chatbot is effective for reducing physical and psychological distress in people undergoing radiotherapy for head and neck cancer.

A single-blinded parallel randomized controlled trial (RCT allocation ratio = 1:1) will be conducted, with baseline data collection at week 1 (T0) and three follow-up timepoints at week 8 (T1), week 12 (T2) following radiotherapy commencement.

Participants in the Treatment-As-Usual group will receive routine onsite nursing care in which the nurse discussed general knowledge of self-care behaviors regarding the management of radiotherapy-related side effects.

Participants in the intervention group will have access to the Digi-Coach chatbot in addition to usual care. The research nurse will provide training on how to navigate the chatbot and ask participants to query all their cancer-related concerns in the chatbot.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged 18 and above
  • are able to read and speak Cantonese or Mandarin fluently
  • have a new, primary diagnosis of head and neck/laryngeal cancer
  • are waiting to receive a full course of curative-intent, external beam radiotherapy with or without chemotherapy
  • have a Karnofsky performance score ≥70
  • have distress scored 3 or above on the NCCN distress thermometer

排除标准

  • insufficient command of Chinese
  • have any other factors precluding the ability to give informed consent or comply with the protocol

研究组 & 干预措施

Treatment-As-Usual Arm

No Intervention

Participants in the Treatment-As-Usual group will receive routine onsite nursing care in which the nurse discusses general knowledge of self-care behaviors regarding the management of radiotherapy-related side effects.

Digi-Coach Chatbot Arm

Experimental

Participants in Digi-Coach Chatbot Arm will have access to the Digi-Coach chatbot in addition to usual care. The research nurse will provide training on how to use the chatbot.

干预措施: Digi-Coach Chatbot (Other)

结局指标

主要结局

National Comprehensive Cancer Network Distress Thermometer

时间窗: 1 week, 8 weeks, and 12 weeks

A 2-item measurement that has participants first rate their distress levels on a scale of 0 (no distress) to 10 (extreme distress) and then self-report their concerns by choosing from a given list of physical, emotional, social, practical, spiritual, or other concerns.

次要结局

  • Memorial Symptom Assessment Scale(1 week, 8 weeks, and 12 weeks)
  • Functional Assessment of Cancer Therapy-Head and Neck(1 week, 8 weeks, and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tongyao WANG

Research Assitant Professor

The University of Hong Kong

研究点 (2)

Loading locations...

相似试验